GHDX
Genomic Health, Inc.
GHDX
GHDX
Delisted
GHDX was delisted on the 7th of November, 2019.
134 hedge funds and large institutions have $1.01B invested in Genomic Health, Inc. in 2017 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 58 increasing their positions, 29 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Holders
134
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$13.6M | |
| 2 | +$2.72M | |
| 3 | +$2.66M | |
| 4 |
Morgan Stanley
New York
|
+$2.62M |
| 5 |
Goldman Sachs
New York
|
+$2.53M |
Top Sellers
| 1 | -$9.02M | |
| 2 | -$8.05M | |
| 3 | -$4.6M | |
| 4 |
SCA
Secor Capital Advisors
New York
|
-$1.51M |
| 5 |
Two Sigma Investments
New York
|
-$1.26M |